基本信息
浏览量:7
职业迁徙
个人简介
Jean-Pierre leads the Stem Cell Biology Research Group at Mater with a team of six researchers.
Jean-Pierre has authored over 100 scientific publications, with a current research focus in the biology of haematopoietic stem cells, the regulation of haematopoiesis and bone formation. He holds four patents and has attracted more than $8 million in competitive grants as the primary or secondary investigator (CIA and CIB).
Jean-Pierre’s lab, having identified many of the pathways by which hematopoietic stem cell niches are dynamically regulated and how they control the behaviour and fate of normal stem cells, are now studying how abnormal niches promote development of haematological neoplasms and their resistance to treatment and cause anaemia. This work has led to the introduction of Plerixafor (an immunoregulator) to salvage haematopoietic stem cell mobilisation for autologous transplantation in multiple myeloma and lymphoma patients. Jean-Pierre’s lab is also interested in discovering new therapeutic approaches in order to change survival rates in patients. A highlight of this research is the discovery of two proteins that make leukaemia stem cells resistant to chemotherapy in the bone marrow and the discovery that targeting these proteins can sensitise leukaemia stem cells to chemotherapy in pre-clinical models of acute myeloid leukaemia (AML). This has led to successful clinical trials in the USA and Australia showing higher rates of remission in AML patients. His research has recently broadened to understand the mechanisms of pathological neurologic bone formation that develops in victims of spinal cord and traumatic brain injury.
Jean-Pierre works closely with clinicians, at Mater and other hospitals, to translate his discoveries into clinical practice and in 2011 was published in Blood, the top haematology journal, guidelines to rescue hematopoietic stem cell mobilisation for autologous transplantation patients.
Jean-Pierre is heavily involved in national and international peer review (including the NHMRC) and has served on the Editorial Boards of two international journals, and is currently an Editor of an international haematology journal.
‘I undertook a career in medical research because I was fascinated by the complex biology of the human being. I focused on understanding how blood cells are made and why it goes wrong in leukaemia because blood cancers were a dreadful disease with poor outcomes and invasive treatments when I was studying. Over the years, I have had immense satisfaction to make discoveries that are used clinically to make haematopoietic stem cell transplants easier and improve patient outcomes.’
Jean-Pierre has authored over 100 scientific publications, with a current research focus in the biology of haematopoietic stem cells, the regulation of haematopoiesis and bone formation. He holds four patents and has attracted more than $8 million in competitive grants as the primary or secondary investigator (CIA and CIB).
Jean-Pierre’s lab, having identified many of the pathways by which hematopoietic stem cell niches are dynamically regulated and how they control the behaviour and fate of normal stem cells, are now studying how abnormal niches promote development of haematological neoplasms and their resistance to treatment and cause anaemia. This work has led to the introduction of Plerixafor (an immunoregulator) to salvage haematopoietic stem cell mobilisation for autologous transplantation in multiple myeloma and lymphoma patients. Jean-Pierre’s lab is also interested in discovering new therapeutic approaches in order to change survival rates in patients. A highlight of this research is the discovery of two proteins that make leukaemia stem cells resistant to chemotherapy in the bone marrow and the discovery that targeting these proteins can sensitise leukaemia stem cells to chemotherapy in pre-clinical models of acute myeloid leukaemia (AML). This has led to successful clinical trials in the USA and Australia showing higher rates of remission in AML patients. His research has recently broadened to understand the mechanisms of pathological neurologic bone formation that develops in victims of spinal cord and traumatic brain injury.
Jean-Pierre works closely with clinicians, at Mater and other hospitals, to translate his discoveries into clinical practice and in 2011 was published in Blood, the top haematology journal, guidelines to rescue hematopoietic stem cell mobilisation for autologous transplantation patients.
Jean-Pierre is heavily involved in national and international peer review (including the NHMRC) and has served on the Editorial Boards of two international journals, and is currently an Editor of an international haematology journal.
‘I undertook a career in medical research because I was fascinated by the complex biology of the human being. I focused on understanding how blood cells are made and why it goes wrong in leukaemia because blood cancers were a dreadful disease with poor outcomes and invasive treatments when I was studying. Over the years, I have had immense satisfaction to make discoveries that are used clinically to make haematopoietic stem cell transplants easier and improve patient outcomes.’
研究兴趣
论文共 231 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current Osteoporosis Reportsno. 1 (2024): 80-95
Katie E Lineburg, Lucie Leveque-El Mouttie,Christopher R Hunter, Laetitia Le Texier,Crystal McGirr,Bianca Teal,Bruce R Blazar,Steven W Lane,Geoffrey R Hill,Jean-Pierre Lévesque,Kelli P A MacDonald
Blood advancesno. 8 (2024): 2032-2043
Methods in molecular biology (Clifton, N.J.) (2023): 43-61
JOURNAL OF BONE AND MINERAL RESEARCH (2023): 204-205
引用0浏览0引用
0
0
JOURNAL OF BONE AND MINERAL RESEARCH (2023): 205-205
引用0浏览0引用
0
0
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn